These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4128697)

  • 1. [Method for determination of the heparin cofactor in blood plasma].
    Chumakov VN
    Lab Delo; 1973; 9():523-5. PubMed ID: 4128697
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heparin cofactor level in the initial stage of acute leukoses. Reduction of this factor by asparaginase].
    Kolodie L; Leger J; Hollard D
    Lyon Med; 1972 Dec; 228(19):685-90. PubMed ID: 4662035
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J; von Pape KW; Blaurock M
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin assay: a comparison between titrimetric and amidolytic methods.
    Nenci GG; Berrettini M; Agnelli G; Parise P
    Boll Soc Ital Biol Sper; 1980 Mar; 56(5):519-25. PubMed ID: 7387799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of activity of antithrombin III - heparin in blood].
    Katsadze IuL; Kotovshchikova MA
    Lab Delo; 1982; (4):232-4. PubMed ID: 6177911
    [No Abstract]   [Full Text] [Related]  

  • 6. Elimination of intravenously administered radiolabelled antithrombin III and heparin in humans.
    de Swart CA; Nijmeyer B; Andersson LO; Holmer E; Sixma JJ; Bouma BN
    Thromb Haemost; 1984 Aug; 52(1):66-70. PubMed ID: 6495266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The progressive antithrombin (antithrombin-III, heparin-cofactor).
    Pálos LA
    Haematologia (Budap); 1974; 8(1-4):455-9. PubMed ID: 4461431
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heparin and antiheparin in young children. 1. Report: development of a method for determining heparin and antiheparin in the antithrombin-thrombin system].
    Domula M; Weissbach G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(5):808-23. PubMed ID: 6188669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of heparin cofactor II on the antithrombin III activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women].
    Akai Y; Shiga S; Tohyama K; Shimatsu A; Ichiyama S
    Rinsho Byori; 2000 Sep; 48(9):867-71. PubMed ID: 11051806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antithrombin III and heparin].
    Ukita M
    Rinsho Byori; 1987 Apr; Spec No 70():173-80. PubMed ID: 3302387
    [No Abstract]   [Full Text] [Related]  

  • 12. [Automatization of heparin determination using chronometric evaluation of anti-Xa activity of the AT III-heparin complex].
    Sampol J; Rossi JM; Lejay G
    Ann Biol Clin (Paris); 1984; 42(1):21-3. PubMed ID: 6731952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid quantitation of plasma heparin and antithrombin III levels for cardiopulmonary bypass monitoring, using fluorometric substrate assays.
    Savidge GF; Kesteven PJ; Al-Hasani SF; O'Brien PF
    Thromb Haemost; 1983 Oct; 50(3):745-8. PubMed ID: 6648894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of calcium pangamate on serum heparin co-factor levels].
    Kaptiukh RF
    Vrach Delo; 1971 Oct; 10():64-6. PubMed ID: 5142537
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of multiple intravenous injections of heparin on the content of antithrombin III in healthy animals and experimental atherosclerosis].
    Kudriashov BA; Pastorova VE; Bazaz'ian GG; Liapina LA
    Vopr Med Khim; 1984; 30(1):82-6. PubMed ID: 6710943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antithrombin III (AT-III) and low dosage heparin therapy. The prognostic value of AT-III in acute myocardial infarction].
    Mortensen SA; Remvig L; Als OS; Andreasen T
    Ugeskr Laeger; 1983 Apr; 145(14):1056-9. PubMed ID: 6346625
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of heparin with histidine-rich glycoprotein and with antithrombin III.
    Lijnen HR; van Hoef B; Collen D
    Thromb Haemost; 1983 Aug; 50(2):560-2. PubMed ID: 6415849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.
    Avidan MS; Levy JH; van Aken H; Feneck RO; Latimer RD; Ott E; Martin E; Birnbaum DE; Bonfiglio LJ; Kajdasz DK; Despotis GJ
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The changes and relation among platelet function, plasma heparin and anti-coagulation-III: activity in patients with hemorrhagic fever with renal syndrome].
    Wei L; Pan X; Yu Y; Lu Q
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):163-5. PubMed ID: 15619827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The determination of heparin].
    Aiach M
    Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.